BioHorizons, Inc., a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ:HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit biohorizons.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $1.50M | - | 19 Dec 2012 | |
Venture Round | $12.56M | - | 11 Nov 2011 | |
Debt Financing | $50.00M | 2 | Deerfield, Piper Jaffray | 30 Jun 2011 |
No recent news or press coverage available for BioHorizons.